Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Neoadjuvant HER2+
Brain Cancer
Bone Metastases
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Precision Medicine in Oncology
®
Sarcomas
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
OS by PS in Metastatic Pancreatic Cancer Treatment- Data From an Exploratory Subgroup Analysis
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Neoadjuvant HER2+
More >>
OncLive TV: A. David McCollum, MD
<< Back to Our Featured Experts
Dr. McCollum on the Clinical Utility of Regorafenib in mCRC
Dr. McCollum on Maintenance Therapy for Metastatic CRC
Dr. McCollum on Molecular Testing in CRC
Dr. McCollum on Frontline Therapy for Patients With Metastatic CRC
Dr. McCollum Discusses Immunotherapy in CRC
Dr. McCollum on Drug Sequences for Patients With CRC
Dr. McCollum on Treatment in the First-Line Setting for CRC
Oncology Specialists
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Joanne Xiu, PhD
FDA Approvals in Myeloma and aTTP, Priority Review Designations in RCC and HNSCC, and More
Trending Now
Novel CLL Regimens Show Promising Efficacy
FDA Grants Pembrolizumab Priority Review for Advanced SCLC
Mesa Explores Role of Interferon in Evolving MPN Treatment Paradigm
Expert Highlights Encouraging PFS Data With Maintenance Ixazomib in Multiple Myeloma
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x